VEGF-mediated suppression of cell proliferation and invasion by miR-410 in osteosarcoma (Q38941347)

7 September 2017

title

VEGF-mediated suppression of cell proliferation and invasion by miR-410 in osteosarcoma (English)

1 reference

7 September 2017

Dong Zhao

1

1 reference

7 September 2017

Peng Jia

series ordinal

2

1 reference

7 September 2017

Wenliang Wang

series ordinal

3

1 reference

7 September 2017

Guangling Zhang

series ordinal

4

1 reference

7 September 2017

publication date

11 November 2014

1 reference

Molecular and Cellular Biochemistry

7 September 2017

published in

1 reference

7 September 2017

volume

400

1 reference

7 September 2017

issue

1-2

1 reference

7 September 2017

page(s)

87-95

1 reference

Multidisciplinary approach to diagnosis and management of osteosarcoma - a review of the St Vincent's Hospital experience.

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11010-014-2265-2

Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11010-014-2265-2

Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11010-014-2265-2

The art of microRNA research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11010-014-2265-2

MicroRNAs, macrocontrol: regulation of miRNA processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11010-014-2265-2

miR-1 overexpression enhances Ca(2 ) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11010-014-2265-2

Discovery of pluripotency-associated microRNAs in rabbit preimplantation embryos and embryonic stem-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11010-014-2265-2

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11010-014-2265-2

A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11010-014-2265-2

Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11010-014-2265-2

Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11010-014-2265-2

MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11010-014-2265-2

MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11010-014-2265-2

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11010-014-2265-2

miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11010-014-2265-2

Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11010-014-2265-2

MiR-410 regulates MET to influence the proliferation and invasion of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11010-014-2265-2

Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11010-014-2265-2

Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11010-014-2265-2

VEGF/VEGFR2 interaction down-regulates matrix metalloproteinase-9 via STAT1 activation and inhibits B chronic lymphocytic leukemia cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11010-014-2265-2

VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11010-014-2265-2

Inhibition of VEGF blocks TGF-beta1 production through a PI3K/Akt signalling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11010-014-2265-2

miR-34a inhibits the metastasis of osteosarcoma cells by repressing the expression of CD44.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25385479

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25385479

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11010-014-2265-2

1 reference

Dimensions Publication ID

7 September 2017

1035007211

0 references

1 reference